ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own immune cells beat advanced melanoma?
Disease control CompletedThis trial tested a new treatment called GC101 TIL for people with advanced melanoma that has not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in a lab, and then given back to the patient. The study enrolled 18 partici…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Your own tumor cells could be the key to fighting cancer
Disease control CompletedThis early-phase trial tested a personalized immunotherapy for people with advanced solid tumors. Doctors removed a sample of each patient's tumor, grew the immune cells (TILs) in a lab, and then infused them back along with another drug. The goal was to see if this approach is s…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tracks COVID-19 vaccine side effects in kids ages 5 to 16
Knowledge-focused CompletedThis study follows children and adolescents aged 5 to 16 who receive an mRNA COVID-19 vaccine to monitor for side effects like injection site pain, fever, and other reactions. Participants report symptoms for a week after each dose, and some provide blood samples to measure antib…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 02, 2026 03:00 UTC
-
New scoring tool aims to predict Drug-Related ER returns
Knowledge-focused CompletedThis study tested a risk prediction tool called ADE-RED, designed to identify emergency department patients at high risk for drug-related hospital readmissions. Researchers followed 471 patients to see if using the tool could reduce repeat visits. The goal is to improve discharge…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Over 1 million records reviewed to check safety of nighttime urination drug
Knowledge-focused CompletedThis study looked at medical records from Denmark, Sweden, and Germany to see how safe NOCDURNA is for people who wake up often at night to urinate due to a condition called nocturnal polyuria. Researchers tracked serious side effects like low sodium levels in the blood. The stud…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC